Key result
Hypertensive patients treated with atenolol alone had higher mean AST levels compared to those taking atenolol in combination with other antihypertensive drugs and healthy controls.
Why the study?
Atenolol is widely used to treat hypertension but has been found to significantly affect hepatic functions.
Does atenolol increase AST levels in hypertensive patients?
Observational (n=100)
No
Does atenolol increase AST levels in hypertensive patients?
Atenolol use in hypertensive patients is associated with elevated AST levels, suggesting a risk of hepatic dysfunction that may be lower when used in combination with other antihypertensive drugs.
Answers are grounded in this paper and cite their sources.
Atenolol monotherapy was associated with higher AST in this small cohort; leaves open whether combination regimens mitigate risk pending larger prospective studies.
Hypertension is one of the most important risk factors for morbidity and mortality around the world. Many drugs used to treat hypertension have several side effects. Atenolol used to control hypertension, is an anti-beta-adrenergic agent. It has found to significantly affect the hepatic functions. Objective: To study the effects of atenolol on hepatic dysfunction by measuring AST level in hypertensive patients, taking atenolol alone or in combination with other anti-hypertensive drugs. Methods: The variation in AST level was measured upon use of atenolol alone or in combination with other anti-hypertensive drugs. Out of total 80 patients, 43 were treated with atenolol alone, 37 with atenolol in combination with other anti-hypertensive drugs and 20 were healthy controls. Micro lab tests were used for measurement of AST level. Results: Significant results were found as atenolol cause increase in AST level. Other anti-hypertensive drugs did not affect the AST levels much and the increase in AST level was more significant in patients taking atenolol alone. Conclusions: Atenolol may have efficacy in controlling hypertension, but it causes disturbance in AST levels therefore any other drug in combination with atenolol is recommended to avoid AST variation and eventually hepatic dysfunctions. Further this study may be employed on large scale for strengthening the outcomes of this study
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2023) conducted an observational in Hypertension (n=100). Atenolol vs. Atenolol in combination with other anti-hypertensive drugs, and healthy controls was evaluated on AST level (p=0.049). Hypertensive patients treated with atenolol alone had higher mean AST levels compared to those taking atenolol in combination with other antihypertensive drugs and healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: